WAXSOL Ear drops Ref.[8431] Active ingredients: Docusate

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2019  Publisher: Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom

Contraindications

Perforation of the ear drum or inflammation of the ear.

Special warnings and precautions for use

If pain or inflammation is experienced, treatment should be discontinued.

Interaction with other medicinal products and other forms of interaction

None known.

Pregnancy and lactation

There is no evidence to suggest that Waxsol Ear Drops should not be used during pregnancy and lactation.

Effects on ability to drive and use machines

None known.

Undesirable effects

Immune system disorders: Hypersensitivity/allergic reactions.

Skin disorders: Contact dermatitis and allergic skin reactions.

General disorders: Application site reactions rarely including transient stinging or irritation may occur. Injuries or inflammation in the auditory canal may result in painful symptoms.

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

Incompatibilities

None known.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.